-
Total IgE ELISACatalog #: 25-IGEHU-E01
Sensitivity: 5.0 IU/mL
Range: 10 - 800 IU/mL
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Canine IgE ELISA
Catalog #: 41-IGECA-E01
Sensitivity: 6.25 ng/mL
Range: 6.25-400 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Feline IgE ELISA
Catalog #: 41-IGEFE-E01
Sensitivity: 12.5 ng/mL
Range: 12.5-400 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Mouse IgE ELISA
Catalog #: 41-IGEMS-E01
Sensitivity: 6.25 ng/mL
Range: 6.25-400 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Rat IgE ELISA
Catalog #: 41-IGERT-E01
Sensitivity: 1.0 ng/mL
Range: 1.0-32.0 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
IgE ELISA
Catalog #: 41-IGEHU-E01
Sensitivity: 3.1 ng/ml
Range: 3.1 ng/ml - 200 ng/ml
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
ALEX² Allergy Explorer Kit (20 tests)Catalog #: 87-02-2001-02
Sample Types: Plasma, Serum
Sample Size(s): Other
-
ALEX² Allergy Explorer Kit (50 tests)Catalog #: 87-02-5001-02
Sample Types: Citrate Plasma, Heparin Plasma, Serum
Sample Size(s): 50 Tests
Multiplex Allergy
MADx Multiplex Allergy Assays &
InstrumentationALPCO is the exclusive North American distributor for the MADx ALEX2 platform for multiplex IgE allergy detection and the FOX platform for detection of IgG-mediated food intolerance.MAX
45k for Automated Sample ProcessingThe MAX 45K is a fully aut...
Responsibility
ALPCO’s Diabetes Research Travel GrantALPCO strives to provide scientists and healthcare professionals with robust tools for their research and clinical diagnostic endeavors. We understand that championing extraordinary discoveries requires extraordinary efforts, and support. We are proud to continu...
Clinical Research
New: Calprotectin Immunoturbidimetric Assay will take your testing to the next level. Learn more.ALPCO has been serving the needs of clinical researchers and clinical diagnostics labs for over 30 years, and we now offer a broad product menu of proprietary automated sample-to-answer platforms. We’re ...
Platforms
Our platforms offer walk-away, sample-to-answer solutions for life science research, clinical research, and diagnosticsALPCO is a global leader in platforms for immunodiagnostics and molecular diagnostics. Our proprietary automated sample-to-answer solutions provide efficiency and ease-of-use for th...
Next-Gen Multiplex Allergy Testing with MADx
ALPCO has partnered with MacroArray Diagnostics, MADx, to offer a comprehensive testing solution for IgE-based allergies. MADx’s multiplex allergy test incorporates allergens covering 99% of globally relevant allergens, including pollen, pet allergens, dust mites, insect venom, foods, and mo...
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts?
The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50+ unique molec...
Food Intolerance Testing with MADx
ALPCO has partnered with MacroArray Diagnostics, MADx, to offer a comprehensive testing solution for IgG-based food intolerances. MADx’ multiplex food test offers a complete repertoire of relevant food antigens, including dairy, nuts, fruits/vegetables, spices and also superfoods such as alo...
The Role of IgE and IgG in Allergy Testing
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives...
Featured Biomarkers from A to Z
This handout briefly describes the role of several important hormones measured in research.
Diagnostic Testing in GI Health
60 to 70 million Americans are affected by gastrointestinal (GI) diseases and disorders each year. The estimated annual U.S. cost associated with GI disorders is over 140 billion dollars. Gl diseases and disorders can have a significant impact on quality of life, often contributing to anxiety ...
Total IgG vs. IgG4 Testing
The use of serological testing for the detection of allergen sensitization, food intolerance, and the development of allergen tolerance is rapidly expanding. In addition to traditional IgE testing, a growing number of IgG tests are entering the market. Some tests measure total IgG, while others ...
ALEX² Allergy Xplorer
Simultaneous measurement of total IgE (tlgE) and specific IgE (slgE) against 300 allergen extracts and molecular allergens.
-Explore potential sensitization to 300 allergens-Test 50+ unique molecular allergens-Obtain accurate results with automatic blocking of IgE antibodies with reactivity to cros...
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives...
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food observe...
Differentiating Gastrointestinal Pathogens from IBD and IBS
Gastrointestinal (GI) disorders such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), as well as infections from GI pathogens can present very similar symptoms. A host of tests have been developed to aid in the differentiation between IBD and IBS, such as calprotectin and lact...
Role of IGF-1 in the Growth Hormone/IGF Axis
The Growth Hormone/IGF axis consists of IGF-1, IGF-2 and several high and low affinity IGF Binding Proteins (IGFBP). The whole system is tightly regulated by a feedback loop involving Growth Hormone (GH) secreted by the pituitary, and GH production and secretion controlled by Growth Hormone Releasin...
New Stool-Based Gastroenterology Assays and Extraction Method Can Improve Lab Sample Processing Time By Up To 86%
Date: January 26, 2016
ALPCO recently launched a new panel of 13 stool-based gastroenterology assays that are all compatible with one single extraction step. The unique extraction method allows laboratories to improve their sample processing time by up to 86% by extracting one sample for up to 13...
Measuring Pancreatic Elastase to Diagnose Pancreatic Disease
Many digestive system disorders and diseases can present similar types of symptoms including bloating, diarrhea, constipation, and weight gain/loss. In an effort to rule in or rule out the presence of one disease or the absence of another, clinicians will often turn to clinically approved stool-bas...
Stool-Based Biomarkers to Differentiate Between IBD and IBS
What are IBD and IBS?
Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are two different gastrointestinal tract issues affecting millions of people every day. Although there is some overlap between symptoms of IBD and IBS, differences still remain in regards to pathologies, risks...
Class IA PI3K Inhibitor Cancer Therapies
Date: August 16, 2016
Author: Andrea Tarbet, Product Marketing Associate at ALPCO
Bruton’s tyrosine kinase (BTK) inhibitors are not the only kinase inhibitors to enter the fight against B cell cancers. Since there are numerous subtypes of Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), p...
PI3K Delta Signaling in Rheumatoid Arthritis
Date: September 6, 2016
Author: Andrea Tarbet, Product Marketing Associate at ALPCO
Signaling pathways dictate the differentiation, activation, and functions of immune cells. Even the slightest problem in one cell signaling pathway can transform the immune system and turn it against the body,...
[Infographic] The Benefits of Therapeutic Drug Monitoring for IBD
The Burden of Inflammatory Bowel Disease in the US and Canada
More than 1 million people in the US and 200,000 people in Canada are currently living with inflammatory bowel disease (IBD). This number is projected to grow exponentially over the next 10 years1,2. As the prevalence of IBD increases, s...
Emerging Biomarker Research in NAFLD and NASH
Nonalcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease in the western hemisphere affecting 1 in 3 adults and 1 in 10 children1. Today, liver biopsies are the only gold standard for precise diagnosis of NAFLD2. Because of this, there are tremendous efforts on the ...
New Zonulin ELISAs and Therapeutic Drug Monitoring Assays for IBD to be Launched at Digestive Disease Week®
We are excited to announce that we will launch new gastrointestinal and inflammatory bowel disease (IBD) assays at Digestive Disease Week® May 7-9, 2017 in Chicago, IL. Included in this release are the Zonulin Stool ELISA and Zonulin Serum ELISA to aid in the study of gut permeability and celiac dis...